![]() |
市場調查報告書
商品編碼
1691674
蛋白質體學研究工具與診斷市場(全球)(2024-2030 年)Proteomics Research Tools and Diagnostics Market, Global, 2024-2030 |
蛋白質體學產業呈現轉型成長,由蛋白質體學分析和生物標記發現的進步推動
在研究和製藥領域的推動下,全球蛋白質體學研究工具和診斷市場預計將在 2024-2030 年間實現高成長並達到重大收益里程碑。精準醫療日益成長的需求以及蛋白質體學在轉化研究、生物標記發現和藥物開發過程中的顯著優勢正在推動這一強勁成長。
本報告研究了全球蛋白質體學研究工具和診斷市場,並評估了推動和限制在臨床和研究環境中使用蛋白質體學研究工具和診斷的因素。此外,該報告還對北美、歐洲、亞太、拉丁美洲、中東和非洲以及南美 (MEASA) 地區以及每個地區的主要參與企業進行了分析。
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing demand for precision medicine, along with the substantial benefits of proteomics in translational research, biomarker discoveries, and drug development processes, lead to this robust growth.
This analysis assesses the factors driving and restraining the use of proteomics research tools and diagnostics in clinical and research settings. In addition, it offers a regional analysis for North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA); major companies participating in each region are also analyzed. The study also identifies the major growth opportunities by evaluating the industry segments, regulatory environment, and emerging business models, as well as revenues and forecasts.